Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sébastien Hascoët is active.

Publication


Featured researches published by Sébastien Hascoët.


American Journal of Cardiology | 2012

Prognostic Usefulness of Clinical and Subclinical Peripheral Arterial Disease in Men With Stable Coronary Heart Disease

Frédéric Bouisset; Vanina Bongard; Jean-Bernard Ruidavets; Sébastien Hascoët; Dorota Taraszkiewicz; Jérôme Roncalli; Didier Carrié; Michel Galinier; Meyer Elbaz; Jean Ferrières

The prognostic value of symptomatic peripheral arterial disease (PAD) in patients with coronary heart disease (CHD) is well documented, but few reports differentiating between symptomatic and asymptomatic forms of PAD are available. We investigated the respective prognostic effect of clinical and subclinical PAD on long-term all-cause mortality in patients with stable CHD. We analyzed 710 patients with stable CHD referred for hospitalization for CHD evaluation and management. As a part of the study, they completed questionnaires on medical history, underwent a standardized clinical examination, including ankle-brachial index (ABI) measurement, and provided a fasting blood sample. Three groups of patients were individualized: no PAD (no history of PAD and ABI >0.9 but ≤1.4); subclinical PAD (no history of PAD but abnormal ABI [i.e., ≤0.9 or >1.4); and clinical PAD (history of claudication, peripheral arterial surgery, or amputation due to PAD). Clinical and subclinical PAD was present in 83 (11.7%) and 181 (25.5%) patients, respectively. After a median follow-up of 7.2 years, 130 patients died. On multivariate analysis adjusted for age, hypertension, diabetes, dyslipidemia, smoking, left ventricular ejection fraction, CHD duration, heart rate, history of stroke or transient ischemic attack, and coronary revascularization, previous clinical PAD (hazard ratio 2.11, 95% confidence interval 1.28 to 3.47) and subclinical PAD (hazard ratio 1.65, 95% confidence interval 1.11 to 2.44) were significantly associated with increased all-cause mortality. In conclusion, our study has demonstrated that the detection of subclinical PAD by ABI in patients with stable CHD provides additional information for long-term mortality risk evaluation.


European Journal of Pediatrics | 2015

From adolescents to adults with congenital heart disease: the role of transition

Pamela Moceri; Eva Goossens; Sébastien Hascoët; Carine Checler; Béatrice Bonello; Emile Ferrari; Philippe Acar; Alain Fraisse

AbstractImproved surgical care during the last decades, together with advances in medical management, led to a remarkable increase in survival of patients with congenital heart disease (CHD). However, aging of the CHD population brings new challenges, and loss of follow-up of adolescents and adults with CHD is a major concern. It is crucial to optimize the transfer of patients with CHD from paediatric to adult health care services to prevent loss to follow-up. The transition process plays a central role in the future health and follow-up of the patient. The aim of this review is to explain and discuss the clinical impact of the transition process in adolescents with CHD. We will also discuss specific CHD adolescents’ problems. Conclusion: Adolescence is a crucial phase for the formation of the personality. Understanding and acceptance of the responsibility for health at this stage through a transition process with a multidisciplinary team will determine the quality of future medical follow-up and probably limit psychosocial issues in their adult life.What is known:• Aging of the congenital heart disease population brings new challenges to the organisation of care.• Loss of follow-up is a major concern for patients with congenital heart disease.What is new:• The quality of a formal transition process during adolescence will determine future outcomes in patients with congenital heart disease.


Canadian Journal of Cardiology | 2016

Long-term Complications After Transcatheter Atrial Septal Defect Closure: A Review of the Medical Literature

Zakaria Jalal; Sébastien Hascoët; Alban-Elouen Baruteau; Xavier Iriart; Bernard Kreitmann; Younes Boudjemline; Jean-Benoit Thambo

Percutaneous closure has evolved to become the first-line treatment strategy for most cases of secundum atrial septal defect (ASD) in both adults and children. Its safety and efficacy have been proved; percutaneous ASD occlusion offers many advantages over surgical closure, including avoidance of cardiopulmonary bypass, avoidance of sternotomy scar, shorter hospitalization, and a potentially lower incidence of postprocedural complications. Periprocedural course and short-term outcome have been widely described, with low mortality and morbidity rates. However, the wide use of ASD closure devices and the growing experience worldwide brought some delayed and rare complications to light. Device thrombosis and cardiac erosion are the most severe late complications of device closure, whereas atrial arrhythmias are the most common. Other delayed complications include nickel allergy, cardiac conduction abnormalities, valvular damage, and device endocarditis. The long-term complication rate is not null and, although rare, some of these complications may be sudden and potentially life-threatening. Moreover, the occurrence and rate of these complications vary with the different devices used currently or in the past. Therefore, both operators and patients need to be aware of these issues to assist them in the choice of intervention or device, or both, and to adapt follow-up modalities. In this review, we sought to describe the type, incidence, and outcome of these rare but potentially serious device closure delayed complications.


Archives of Cardiovascular Diseases | 2012

Early triage of emergency department patients with acute coronary syndrome: Contribution of 64-slice computed tomography angiography

Sébastien Hascoët; Vanina Bongard; V. Chabbert; Marie-Agnès Marachet; Hervé Rousseau; Sandrine Charpentier; Frédéric Bouisset; Benjamin Honton; Olivier Lairez; Pauline Marchal; Matthieu Berry; Didier Carrié; Michel Galinier; Meyer Elbaz

BACKGROUND Multislice computed tomography coronary angiography (MSCT-CA) is feasible in the emergency department (ED) for ruling out obstructive coronary artery disease (CAD). AIM To investigate a diagnostic strategy using MSCT-CA for the early triage of patients presenting to the ED with acute chest pain suggestive of acute coronary syndrome (ACS), according to the medium-term incidence of clinical events. METHODS We conducted a single-centre, prospective, observational cohort study in 123 patients with low-risk to intermediate-risk acute chest pain suggestive of ACS. MSCT-CA was performed using dual-source 64-slice computed tomography with retrospective electrocardiographic gating. Patients without coronary artery lesions were discharged from the ED. The incidences of death, myocardial infarction and myocardial revascularization were collected during a mid-term follow-up. RESULTS According to MSCT-CA, 93 patients (75.6%) had no CAD or coronary artery stenosis less or equal to 50% and 28 patients (22.8%) had stenosis more or equal to 50%. Invasive coronary angiography was performed in 29 patients (23.6%). MSCT-CA accurately identified ten patients (8.13%) with obstructive CAD requiring myocardial revascularization; all had a low TIMI score (0-2) and eight had a low GRACE score. The mean estimated effective dose of MSCT-CA was 16.3±6.4 mSv. Median follow-up was 15 months. No patient (95% CI 0-3.0%) had major adverse cardiovascular events during follow-up. CONCLUSION MSCT-CA appears to be a useful initial triage tool in the ED. When the MSCT-CA result is negative, it allows safe early discharge because of its high negative predictive value. In a significant number of cases of low-risk ACS, MSCT-CA detects severe coronary lesions and allows further dedicated diagnostic and therapeutic intervention. Reduction of radiation exposure would help acceptance in clinical practice.


Echocardiography-a Journal of Cardiovascular Ultrasound and Allied Techniques | 2011

The Gerbode Defect or Left Ventricular to Right Atrial Shunt Assessed by Transthoracic 3D Echocardiography

Philippe Acar; Pierre-Emmanuel Séguéla; Sébastien Hascoët

We report the case a 14‐year‐old male presented with a perimembranous ventricular septal defect. 2D echocardiography showed both left ventricular to right ventricular and atrial shunt. Left and right ventricular 3D “en face” views of the defect were obtained. 3D echocardiography delineated the morphologic nature of the ventricular septal defect, its shape, and the direction in which the defect extends into the ventricular septum. Other anatomic structures such as the tricuspid valve leaflet, the right ventricular outflow tract, and the aortic valve can be displayed in their realistic spatial distribution. These findings have clinical implications when surgical repair is planned. (Echocardiography 2011;28:E140‐E142)


Journal of Thoracic Disease | 2017

Transthoracic echocardiography is a safe alternative for assessment and guidance of transcatheter closure of secundum atrial septal defect in children

Alban-Elouen Baruteau; Sébastien Hascoët; Alain Fraisse

BACKGROUND 2D-transesophageal echocardiography (TEE) is routinely performed to guide percutaneous ASD closure in children. We aimed to assess whether two-dimensional (2D)-transthoracic echocardiography (TTE) is a safe alternative for assessment and guidance of atrial septal defect (ASD) closure in unselected children. METHODS We performed a retrospective single-center study including 389 consecutive children aged less than 15-year-old who underwent percutaneous ASD closure under 2D-TEE (1998-2005, n=133) or 2D-TTE (2005-2014, n=256). A balloon calibration was performed in all cases for the Amplatz Septal Occluder choice. RESULTS ASDs were larger and rims deficiencies were more frequent in the TTE-guided group. The procedure was successful in 376 patients [96.7%; 95% confidence interval (CI), 94.4-98.2%]. The success rate tended to be higher in the TTE- versus TEE-guided group (98.0% versus 94.0%, P=0.069). Device migration occurred in 4 patients (1.0%; 95% CI: 0.3-1.6%), all after TEE-guided procedure (P=0.013). Early major adverse events were observed in 5 patients (1.3%; 95% CI: 0.4-3.0%), all in the TEE group (P=0.004). Fluroroscopic time and irradiation dose were not different among the 2 groups (P=0.450 and P=0.130 respectively). After a median follow-up of 7 years (range, 1-16 years), no adverse events was reported. One (0.3%, 95% CI: 0-1.4%) 12-year-old patient developed atrial fibrillation 5 years after the procedure. Pregnancies were uneventful in 72 cases. CONCLUSIONS When a balloon sizing is performed, 2D-TTE imaging is as efficient as 2D-TEE to guide percutaneous ASD closure in children. The procedure can safely be done in spontaneously breathing children under TTE guidance alone in experienced centers.


International Journal of Cardiology | 2013

Transcatheter therapy in partially abnormal pulmonary venous return with additional drainage to the left atrium

Debora Luciano; Daniela Laux; Younes Boudjemline; Sébastien Hascoët; Jean-René Lusson; Clio Sorensen; Caroline Ovaert; Bernard Kreitmann; Richard Van Praagh; Alain Fraisse

BACKGROUND A persistent anastomosis between the pulmonary veins that connect with the left atrium and the systemic vein that drains into the right atrium has occasionally been reported. We report characteristics and transcatheter therapy in partially abnormal pulmonary venous return with additional drainage to the left atrium. METHODS We retrospectively studied such patients in 5 institutions. RESULTS Ten patients (6 girls) presented at a median age of 8 (0.1 to 54) years with 2 anatomic types: 8 vertical vein types with drainage of the left upper lobe to the innominate vein via a large vertical vein (left superior cardinal vein) and to the left atrium via the left upper pulmonary vein; and 2 scimitar vein (SV) types with drainage of the right middle and lower pulmonary veins into the inferior vena cava and to the left atrium via an anomalous connecting vein. Associated malformations were aortic coarctation (n=2) and secundum atrial septal defects (n=3). Two patients of the vertical vein type were operated. Transcatheter occlusion of the abnormal pulmonary venous return was performed in 7 cases, associated with occlusion of systemic arterial supply (n=2), secundum atrial septal closure (n=2), left upper pulmonary vein stenosis stenting (n=1), and coarctation stenting (n=1). Including previously published cases, 18 patients (13 vertical veins and 5 scimitar veins) underwent transcatheter repair. Patients over 40 years of age tend to be symptomatic at presentation (p=0.056). CONCLUSION In partially abnormal pulmonary venous return with dual drainage, transcatheter therapy can be offered in the majority of patients.


Circulation | 2017

How Pregnancy Impacts Adult Cyanotic Congenital Heart Disease

Magalie Ladouceur; Louise Benoit; Adeline Basquin; Jelena Radojevic; Quentin Hauet; Sébastien Hascoët; Pamela Moceri; Laurianne Le Gloan; Pascal Amedro; Hugues Lucron; Adélaïde Richard; Marielle Gouton; Jacky Nizard

Survival into adulthood of patients with unrepaired cyanotic congenital heart defects (CHDs) is possible when cyanotic CHDs are deemed unsuitable for radical surgical repair but are compatible with survival. These situations include, for example, complex pulmonary atresia with aortopulmonary collaterals and single-ventricle hearts (with and without earlier palliation). This is also the case when patients with cyanotic CHDs reach adulthood without serious symptoms requiring surgery, such as those with mild tetralogy of Fallot, Ebstein’s anomaly, and some cases of corrected transposition of the great arteries with pulmonary stenosis and ventricular septal defect. Many women with these heart conditions wish to become pregnant, which creates a situation of high maternal and fetal risks of complications.1 Management of these patients before, during, and after pregnancy has improved, with an earlier recognition of the underlying disease, improved understanding of cardiopulmonary physiopathology, better prenatal and peri-partum obstetric/anesthetic management, and the introduction of a multidisciplinary approach.2 We retrospectively reviewed the charts of all pregnant women with cyanotic CHDs (n=51) who were followed in 11 adult CHD referral …


Catheterization and Cardiovascular Interventions | 2016

Transcatheter closure of coronary artery fistulas in infants and children: A French multicenter study.

Benoît Mottin; Alban Baruteau; Younes Boudjemline; François J. Piéchaud; François Godart; Jean-René Lusson; Sébastien Hascoët; Laurianne Le Gloan; Karine Warin Fresse; Béatrice Guyomarch; Ivan Bouzguenda; Sophie Malekzadeh-Milani; Jérôme Petit; Patrice Guérin

The short‐term efficacy and safety of transcatheter closure (TCC) for the management of coronary artery fistulas (CAFs) was investigated in pediatric patients.


Catheterization and Cardiovascular Interventions | 2015

Transcatheter : A French multicenter study

Benoît Mottin; Alban Baruteau; Younes Boudjemline; François J. Piéchaud; François Godart; Jean-René Lusson; Sébastien Hascoët; Laurianne Le Gloan; Karine Warin Fresse; Béatrice Guyomarch; Ivan Bouzguenda; Sophie Malekzadeh-Milani; Jérôme Petit; Patrice Guérin

The short‐term efficacy and safety of transcatheter closure (TCC) for the management of coronary artery fistulas (CAFs) was investigated in pediatric patients.

Collaboration


Dive into the Sébastien Hascoët's collaboration.

Top Co-Authors

Avatar

Philippe Acar

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Yves Dulac

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Khaled Hadeed

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Alain Fraisse

Necker-Enfants Malades Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Meyer Elbaz

University of Toulouse

View shared research outputs
Top Co-Authors

Avatar

Bertrand Leobon

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge